Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death
Modern Pathology2015Vol. 29(1), pp. 34–42
Citations Over TimeTop 11% of 2015 papers
Thai H. Ho, Payal Kapur, Richard W. Joseph, Daniel Serie, Jeanette E. Eckel‐Passow, Pan Tong, Jing Wang, Erik P. Castle, Melissa Stanton, John C. Cheville, Eric Jonasch, James Brugarolas, Alexander S. Parker
Related Papers
- → HAVCR/KIM-1 Activates the IL-6/STAT-3 Pathway in Clear Cell Renal Cell Carcinoma and Determines Tumor Progression and Patient Outcome(2014)97 cited
- → Downregulation of ACE2 is associated with advanced pathological features and poor prognosis in clear cell renal cell carcinoma(2021)7 cited
- → Novel model of pyroptosis-related molecular signatures for prognosis prediction of clear cell renal cell carcinoma patients(2024)4 cited
- → CDCA5 is a potent therapeutic target of clear cell renal cell carcinoma(2022)1 cited
- → [The relationship between hazard ratio and median survival time].(2019)